Skip to main navigation Skip to search Skip to main content

Safety and Pharmacokinetics of Odm-208 In Patients With Metastatic Castration-Resistant Prostate Cancer

Project: Research

Project Details

StatusActive
Effective start/end date08/2/21 → 08/1/26

Funding

  • Parexel International LLC: $50,809.08